Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
CUMBERLAND PHARMACEUTICALS INC
Report date April 07, 2017 · Filed April 07, 2017
Section 16 reporting ended · disclosed 2017-04-07. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2017-04-07 transaction · row 1
1 source rowRow 1 · 2017-04-07 · Sale · Disposed 6,000 · Balance 0 F1: Shares transferred to accredited investor |
Filing footnotes · ownership attribution and instrument terms
F1: Shares transferred to accredited investor
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 07, 2017 Filed Apr 7, 2017 21:01 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | SaleCommon Stock | 6,000 | $6.40 | $38,400.00 |
DisclosureSEC source: 0001209191-17-026315 · doc4.xml · nonDerivative · entry 1 Lawrence Thomas R · CIK 0001408568 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: Shares transferred to accredited investor Read SEC document |
| March 13, 2017 Filed Mar 15, 2017 21:00 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | SaleCommon Stock | 20,781 | $6.24 | $129,673.44 |
DisclosureSEC source: 0001209191-17-020844 · doc4.xml · nonDerivative · entry 1 Lawrence Thomas R · CIK 0001408568 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 F1 · shares: Shares transferred to accredited investor Read SEC document |
| November 15, 2016 Filed Nov 18, 2016 22:14 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | SaleCommon Stock | 18,600 | $5.07 | $94,302.00 |
DisclosureSEC source: 0001209191-16-151282 · doc4.xml · nonDerivative · entry 1 Lawrence Thomas R · CIK 0001408568 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,781 F1 · shares: Shares sold to Cumberland Pharmaceuticals Inc. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.